News

CITY

Companies in the news and how they were assessed

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

It has been a week of highs and lows for Japanese prime minister Shigeru Ishiba. On Wednesday he secured a coveted US trade deal. US president Donald Trump had threatened Japan with tariffs as high as

Things haven’t been great for the UK stockmarket over the last two decades. Indeed, the City has been a “serial underachiever”, especially when compared with the US, says Andrew Jones, a portfolio man

Rich pickings: Many in the City of London are fretting about the lack of inward investment, but if there is one financial British product North Americans cannot get enough of it’s pensions, says Liam